+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immunochemicals: Global Strategic Business Report

  • PDF Icon

    Report

  • 312 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4426701

Global Immunochemicals Market to Reach $6.4 Billion by 2030

The global market for Immunochemicals estimated at US$4.2 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 5.1% CAGR

The Immunochemicals market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Select Competitors (Total 116 Featured) -

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Immunochemicals

What is the estimated value of the Global Market for Immunochemicals?

The Global Market for Immunochemicals was estimated to be valued at $4.2 Billion in 2022.

What is the growth rate of the Global Market for Immunochemicals?

The growth rate of the Global Market for Immunochemicals is 5.4%, with an estimated value of $6.4 Billion by 2030.

What is the forecasted size of the Global Market for Immunochemicals?

The Global Market for Immunochemicals is estimated to be worth $6.4 Billion by 2030.

Who are the key companies in the Global Market for Immunochemicals?

Key companies in the Global Market for Immunochemicals include Abcam Plc., Agilent Research Laboratories, Beckman Coulter GmbH, Biolegend Inc., Bio, Rad Laboratories Inc., Cell Signaling Technology Inc., GenScript Biotech Corporation, PerkinElmer Inc. and Rockland Immunochemicals Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Immunochemicals - A Prelude
  • Recent Market Activity
  • Research Antibodies Market: Critical Role in Drug Discovery and Research
  • Key Factors Influencing Purchasing Decisions
  • Citations: One of the Key Factors Driving Research Antibodies’ Purchase
  • The US Dominates the Global Immunochemicals Market
  • Emerging Markets Offer Huge Potential
  • Catalog Antibodies - The Largest Market Segment
  • Custom Antibodies: Finding Favor in Research Applications
  • Primary Antibodies Dominate the Market
  • Competitive Scenario
  • Immunochemicals - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • Abcam Plc. (UK)
  • Agilent Research Laboratories (USA)
  • Biolegend, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Cell Signaling Technology, Inc. (USA)
  • GenScript Biotech Corporation
  • PerkinElmer, Inc. (USA)
  • Rockland Immunochemicals, Inc. (USA)
  • Santa Cruz Biotechnology, Inc. (USA)
  • Merck (Sigma-Aldrich Corporation) (USA)
  • Thermo Fisher Scientific Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Increasing Research Funding Bolsters Market Growth
  • Chinese Market to Become the Largest Investor in Basic Research
  • Cancer Research Drives the Global Immunochemicals Market
  • Cancer Ranks Among the Top Ten Causes of Death Worldwide
  • ‘Reproducibility Crisis’ of Antibodies - A Major Cause of Concern
  • Proper Validation of Antibodies - Vendor Do their Part
  • New Technologies for Antibodies Validation
  • Personalized Medicine Offers New Growth Avenues
  • Rabbit Monoclonal Antibodies Score over Other Animal Antibodies
  • Researchers Prefer Commercial Research to Academic Research
  • Increasing Collaborations between Industry and Academia
  • Beckman Coulter GmbH (USA)
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Immunochemicals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Catalog Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Catalog Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Custom Antibodies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Custom Antibodies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2023 & 2030
  • Table 10: World Immunochemicals Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 11: USA Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 12: USA Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 13: USA 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
CANADA
  • Table 14: Canada Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 15: Canada Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 16: Canada 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
JAPAN
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 17: Japan Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 18: Japan Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 19: Japan 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
CHINA
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 20: China Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: China Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 22: China 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
EUROPE
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 23: Europe Recent Past, Current & Future Analysis for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 24: Europe Historic Review for Immunochemicals by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 25: Europe 18-Year Perspective for Immunochemicals by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2023 & 2030
  • Table 26: Europe Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 28: Europe 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
FRANCE
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 29: France Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: France Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 31: France 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
GERMANY
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 32: Germany Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Germany Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 34: Germany 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
ITALY
  • Table 35: Italy Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Italy Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 37: Italy 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
UNITED KINGDOM
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 38: UK Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: UK Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 40: UK 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
REST OF EUROPE
  • Table 41: Rest of Europe Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: Rest of Europe Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 43: Rest of Europe 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
ASIA-PACIFIC
  • Immunochemicals Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 44: Asia-Pacific Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Asia-Pacific Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 46: Asia-Pacific 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
REST OF WORLD
  • Table 47: Rest of World Recent Past, Current & Future Analysis for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Rest of World Historic Review for Immunochemicals by Type - Catalog Antibodies and Custom Antibodies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 49: Rest of World 18-Year Perspective for Immunochemicals by Type - Percentage Breakdown of Value Sales for Catalog Antibodies and Custom Antibodies for the Years 2012, 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abcam Plc.
  • Agilent Research Laboratories
  • Beckman Coulter GmbH
  • Biolegend Inc.
  • Bio-Rad Laboratories Inc.
  • Cell Signaling Technology Inc.
  • GenScript Biotech Corporation
  • PerkinElmer Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Sigma-Aldrich Corporation
  • Thermo Fischer Scientific Inc.